RBC Bioscience

RBC Bioscience EPS Growth

The EPS Growth of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 231.54 %. In the previous year, EPS Growth was 69.67 % — a change of 232.32% (higher).

EPS Growth

231.54 %

YoY

232.32%

Last updated:

EPS Growth of RBC Bioscience is 2024 231.54 % . EPS Growth of RBC Bioscience was 2023 69.67 % . It decreases by 232.32% higher compared to the previous year.

The RBC Bioscience EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2019
84.82 TWD
Jan 1, 2020
572.09 TWD
Jan 1, 2021
-80.21 TWD
Jan 1, 2022
-87.54 TWD
Jan 1, 2023
69.67 TWD
Jan 1, 2024
231.54 TWD
The RBC Bioscience EPS Growth history
YEAREPS GrowthYoY
231.54 %+232.32%
69.67 %-179.59%
-87.54 %+9.14%
-80.21 %-114.02%
572.09 %+574.50%
84.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

EPS Growth of RBC Bioscience is 231.54 % in 2024.

On Eulerpool you can find the complete historical development of EPS Growth RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — RBC Bioscience

All Key Metrics — RBC Bioscience